Big Pharma Tacks Hard

genomeweb
360dx

Big Pharma Tacks Hard

Jul 11, 2008

While big pharma have tried many things, including tapping smaller biotech firms and outsourcing R&D, trying something new like starting over is notable.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Glaucoma Diagnostic Targeted by Mannin Research, McMaster University Collaboration
NanoString Technologies Plans Common Stock Offering
Abbott Receives CE Mark for Alinity Molecular Diagnostics System, Assays
Oxford Biodynamics Joins UK Prostate Cancer Screening Trial
Microba, Macrogen Form Microbiome Services Alliance
Oncimmune Buys Protagen for £4.1M

The Scan

To See More Clearly

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

Which Fish Is Which?

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

The Suspects, Too

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

This Week in PNAS

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.

Menu